Tabula Rasa Healthcare Inc. (NASDAQ:TRHC) CEO Calvin H. Knowlton sold 8,000 shares of the company’s stock in a transaction that occurred on Wednesday, August 16th. The shares were sold at an average price of $17.21, for a total value of $137,680.00. Following the completion of the sale, the chief executive officer now directly owns 918,362 shares in the company, valued at approximately $15,805,010.02. The transaction was disclosed in a filing with the SEC, which is accessible through this link.

Shares of Tabula Rasa Healthcare Inc. (TRHC) traded down 0.06% on Thursday, hitting $17.31. The company had a trading volume of 112,215 shares. Tabula Rasa Healthcare Inc. has a 12-month low of $10.39 and a 12-month high of $18.25. The company’s market cap is $299.22 million. The company has a 50 day moving average of $15.30 and a 200-day moving average of $14.18.

Tabula Rasa Healthcare (NASDAQ:TRHC) last issued its earnings results on Monday, August 7th. The company reported $0.06 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.06. The company had revenue of $29.70 million during the quarter, compared to analyst estimates of $27.84 million. Tabula Rasa Healthcare had a negative net margin of 10.27% and a negative return on equity of 9.58%. The company’s revenue for the quarter was up 32.6% compared to the same quarter last year. On average, analysts forecast that Tabula Rasa Healthcare Inc. will post $0.40 earnings per share for the current year.

ILLEGAL ACTIVITY NOTICE: “Tabula Rasa Healthcare Inc. (TRHC) CEO Calvin H. Knowlton Sells 8,000 Shares” was published by American Banking News and is the sole property of of American Banking News. If you are accessing this piece on another publication, it was stolen and republished in violation of international copyright and trademark legislation. The correct version of this piece can be accessed at https://www.americanbankingnews.com/2017/08/17/tabula-rasa-healthcare-inc-trhc-ceo-calvin-h-knowlton-sells-8000-shares.html.

A number of equities research analysts recently issued reports on the company. Piper Jaffray Companies reaffirmed an “overweight” rating and issued a $20.00 target price (up previously from $19.00) on shares of Tabula Rasa Healthcare in a research note on Wednesday, August 9th. Robert W. Baird upped their target price on Tabula Rasa Healthcare from $17.00 to $18.00 and gave the company an “outperform” rating in a research note on Tuesday, August 8th. Chardan Capital upped their target price on Tabula Rasa Healthcare from $19.50 to $21.00 and gave the company a “buy” rating in a research note on Tuesday, August 8th. Stifel Nicolaus reaffirmed a “buy” rating and issued a $16.00 target price on shares of Tabula Rasa Healthcare in a research note on Friday, July 14th. Finally, UBS AG reaffirmed a “buy” rating and issued a $17.00 target price (down previously from $18.00) on shares of Tabula Rasa Healthcare in a research note on Thursday, May 25th. One equities research analyst has rated the stock with a hold rating and six have issued a buy rating to the stock. Tabula Rasa Healthcare currently has an average rating of “Buy” and an average price target of $17.83.

Several large investors have recently modified their holdings of TRHC. TIAA CREF Investment Management LLC raised its stake in shares of Tabula Rasa Healthcare by 108.5% in the first quarter. TIAA CREF Investment Management LLC now owns 8,131 shares of the company’s stock worth $110,000 after buying an additional 4,232 shares during the period. New York State Common Retirement Fund raised its stake in shares of Tabula Rasa Healthcare by 257.0% in the second quarter. New York State Common Retirement Fund now owns 10,000 shares of the company’s stock worth $151,000 after buying an additional 7,199 shares during the period. Bank of New York Mellon Corp bought a new stake in shares of Tabula Rasa Healthcare during the first quarter worth about $178,000. Cadence Capital Management LLC bought a new stake in shares of Tabula Rasa Healthcare during the second quarter worth about $210,000. Finally, Teachers Advisors LLC raised its stake in shares of Tabula Rasa Healthcare by 203.5% in the second quarter. Teachers Advisors LLC now owns 16,500 shares of the company’s stock worth $248,000 after buying an additional 11,063 shares during the period. 25.28% of the stock is owned by institutional investors.

Tabula Rasa Healthcare Company Profile

Tabula Rasa HealthCare, Inc (Tabula Rasa), formerly CareKinesis, Inc, is a provider of patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations and manage risk. The Company delivers its solutions through a suite of technology-enabled products and services for medication risk management, which includes bundled prescription fulfillment and adherence packaging services for client populations with complex prescription needs.

Insider Buying and Selling by Quarter for Tabula Rasa Healthcare (NASDAQ:TRHC)

Receive News & Ratings for Tabula Rasa Healthcare Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tabula Rasa Healthcare Inc. and related companies with MarketBeat.com's FREE daily email newsletter.